Acute Leukemias by Unknown

Acute Leukemias by Unknown

Author:Unknown
Language: eng
Format: epub
ISBN: 9783030536336
Publisher: Springer International Publishing


45.

Lee LY, Hernandez D, Rajkhowa T, et al. Preclinical studies of gilteritinib, a next-generation FLT3 inhibitor. Blood. 2017;129:257. https://​doi.​org/​10.​1182/​blood-2016-10-745133.CrossrefPubMedPubMedCentral

46.

Perl AE, Martinelli G, Cortes JE et al (2019) Gilteritinib significantly prolongs overall survival in patients with FLT3-mutated (FLT3mut+) relapsed/refractory (R/R) acute myeloid leukemia (AML): results from the Phase III ADMIRAL trial. Present 2019 AACR Annu Meet March 29 to April 3, 2019, Atlanta, GA Abstr CTPL04



Download



Copyright Disclaimer:
This site does not store any files on its server. We only index and link to content provided by other sites. Please contact the content providers to delete copyright contents if any and email us, we'll remove relevant links or contents immediately.